ANTI-MYELIN-ASSOCIATED GLYCOPROTEIN ASSOCIATED POLYNEUROPATHY

This adverse event was reported 37 times

These drugs are most commonly taken by patients reporting ANTI-MYELIN-ASSOCIATED GLYCOPROTEIN ASSOCIATED POLYNEUROPATHY:

# Drug Count
0 RITUXIMAB 24
1 BENDAMUSTINE HCL 5
2 HUMAN IMMUNOGLOBULIN G 4
3 ALBUTEROL SULFATE 2
4 CHLORAMBUCIL 2
5 IBRUTINIB 2
6 MUPIROCIN 2
7 MUPIROCIN CALCIUM 2
8 PREDNISOLONE 2
9 PREDNISOLONE ORAL 2
See all common drugs associated with ANTI-MYELIN-ASSOCIATED GLYCOPROTEIN ASSOCIATED POLYNEUROPATHY

ANTI-MYELIN-ASSOCIATED GLYCOPROTEIN ASSOCIATED POLYNEUROPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CHLORAMBUCIL 2 0.0005
1 RITUXIMAB-ABBS 2 0.0004
2 BENDAMUSTINE HCL 5 0.0003
3 HUMAN IMMUNOGLOBULIN G 4 0.0002
4 MUPIROCIN CALCIUM 2 0.0001
5 BENDAMUSTINE HYDROCHLORIDE 1 0.0001
6 RITUXIMAB 24 0.0001
7 STANDARDIZED SENNA CONCENTRATE 1 0.0001
8 ROSUVASTATIN CALCIUM 1 0.0000
9 IBRUTINIB 2 0.0000
See all drugs enriched for association with ANTI-MYELIN-ASSOCIATED GLYCOPROTEIN ASSOCIATED POLYNEUROPATHY